pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Ervaxx is pioneering the use of Dark Antigens™ to deliver targeted off-the-shelf cancer vaccines and other immunotherapies for treating and preventing cancer.
LOCATION
London, , UK
Oxford, , uk
THERAPEUTIC AREAS
Oncology
WEBSITE
https://ervaxx.com
CAREER WEBSITE
https://ervaxx.com/careers
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Jan 24, 2020
Ervaxx and Cardiff University Enter Collaboration to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens™
Nov 6, 2019
Ervaxx Launches to Pioneer the Use of Dark Antigens™ for the Development of Off-the-Shelf Cancer Vaccines and T-cell Receptor-based Immunotherapies
For More Press Releases